Classroom Study of SPN-812 in Children With ADHD

Summary

This study will evaluate the efficacy and safety of SPN-812, an extended-release formulation of viloxazine, compared to placebo in children in an analog classroom setting.

Timeline

Start

2019-08

Primary completion

2020-09

Completion

2020-11

Outcome

Outcome not reported

Stopped (Enrollment): “Study stopped before enrollment due to non-safety related corporate decision.”

Drugs

Indications